ABL, Inc., a biomedical contract research and manufacturing organization to the biotechnology and pharmaceutical industry, has been selected by Profectus BioSciences, Inc. to evaluate different delivery regimens of one of its HIV vaccine candidates.
http://ift.tt/1fs0IeK
http://ift.tt/1fs0IeK
No comments:
Post a Comment